Formic Acid

Formic Acid

SCHEMBL25257936

NC(=O)c1ncc[nH]1.O=CO

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
CSNK1A1 P48729 1/20 0.41
TYRO3 Q06418 1/20 0.41
DYRK1B Q9Y463 1/20 0.41
KMT2A Q03164 1/20 0.41
GDA Q9Y2T3 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.33
ALDH1A1 P00352 2/20 0.33
HTT P42858 1/20 0.33
KDM4E B2RXH2 1/20 0.33
PARP1 P09874 1/20 0.33
TBXAS1 P24557 1/20 0.32
ADORA3 P0DMS8 1/20 0.31
TSHR P16473 1/20 0.31
MC4R P32245 1/20 0.31
ADRA1A P35348 1/20 0.31
MC3R P41968 1/20 0.31
GLA P06280 1/20 0.31
BRAF P15056 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL34651 0.92
Hydrochloric Acid SCHEMBL4244388 0.90
SCHEMBL9786602 0.90
Hydrochloric Acid SCHEMBL4023730 0.90 NPC1 (0.47) NPC1RAB9ACSNK1A1TYRO3DYRK1B
Maleic Acid SCHEMBL27580931 0.85 RAB9A (0.41) NPC1RAB9ACSNK1A1TYRO3DYRK1B
Pyrrole SCHEMBL1577642 0.82 CSNK1A1 (0.44) NPC1RAB9ACSNK1A1TYRO3DYRK1B
Pyridine SCHEMBL9978894 0.81 CSNK1A1 (0.42) NPC1RAB9ACSNK1A1TYRO3DYRK1B
SCHEMBL25335480 0.81 CSNK1A1 (0.42) NPC1RAB9ACSNK1A1TYRO3DYRK1B
Pyridine SCHEMBL6603891 0.81 CSNK1A1 (0.42) NPC1RAB9ACSNK1A1TYRO3DYRK1B
SCHEMBL27936752 0.81 NPC1 (0.45) NPC1RAB9ACSNK1A1TYRO3DYRK1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4208454-A1 IMIDAZOLE-PYRAZOLE DERIVATIVES WITH ANTI-BACTERIAL PROPERTIES F. Hoffmann-La Roche AG (CH) 2023-07-12 EP claimed
US-20230295123-A1 NOVEL IMIDAZOLE-PYRAZOLE DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 2023-09-21 US disclosed
EP-4204090-A1 IMIDAZOLE-PYRAZOLE DERIVATIVES AS ANTIBACTERIALS F. Hoffmann-La Roche AG (CH) 2023-07-05 EP disclosed
US-11390604-B2 Imidazole-pyrazole derivatives HOFFMANN-LA ROCHE INC. (US) 2022-07-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11390604-B2 Imidazole-pyrazole derivatives F12, CYP3A7, NLRP3 NPC1 2135/4885RAB9A 342/4885CSNK1A1 677/4885
US-20230295123-A1 NOVEL IMIDAZOLE-PYRAZOLE DERIVATIVES CYP3A7, NISCH, ARG1 NPC1 1034/4885RAB9A 495/4885CSNK1A1 836/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.